Yasuhiro Tamura
Net worth: 97 785 $ as of 2026-05-30
Net worth: 97 785 $ as of 2026-05-30
Yasuhiro Tamura is currently Managing Director & Manager-General Affairs at PhoenixBio Co., Ltd. since 2004.
Mr. Tamura is Chief Financial Officer at KMT Hepatech, Inc. since 2017.
Mr. Tamura is Chief Financial Officer at PhoenixBio USA Corp.
since 2010.
Formerly, Mr. Tamura was Director & Administrative Manager at Oishii Yakusoku KK.
Mr. Tamura was Principal at Suntory Foods Co., Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-30 | 36,800 ( 0.9% ) | 97 785 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| PHOENIXBIO CO., LTD. | Director/Board Member | 2005-05-31 |
PhoenixBio USA Corp.
PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Director of Finance/CFO | 2010-07-31 |
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Director of Finance/CFO | 2017-11-30 |
| Companies | Position | End |
|---|---|---|
Oishii Yakusoku KK | Chief Administrative Officer | - |
Suntory Foods Co., Ltd.
Suntory Foods Co., Ltd. Food DistributorsDistribution Services Sells soft drinks | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
KMT Hepatech, Inc.
KMT Hepatech, Inc. Miscellaneous Commercial ServicesCommercial Services Develops methods to support human liver cells in a mouse that allows support of infections | Commercial Services |
Suntory Foods Co., Ltd.
Suntory Foods Co., Ltd. Food DistributorsDistribution Services Sells soft drinks | Distribution Services |
Oishii Yakusoku KK | |
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
PhoenixBio USA Corp.
PhoenixBio USA Corp. Miscellaneous Commercial ServicesCommercial Services Develops technologies for mass propagation of human cells into laboratory animals | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions